Trial Profile
A Single-center, Open-label Study Evaluating the Pharmacokinetics, and Safety of Multiple Dose Oral Brexpiprazole Tablets (1 mg) in Chinese Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2023
Price :
$35
*
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Agitation; Bipolar disorders; Borderline personality disorders; Major depressive disorder; Pervasive child development disorders; Post-traumatic stress disorders; Schizophrenia; Sleep disorders
- Focus Pharmacokinetics
- Sponsors Otsuka Beijing Research Institute
- 08 Jul 2020 Status changed from active, no longer recruiting to completed.
- 19 Jan 2020 Planned End Date changed from 1 Dec 2019 to 20 Apr 2020.
- 17 May 2019 Status changed from not yet recruiting to active, no longer recruiting.